# Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

> **NCT05029206** · — · COMPLETED · sponsor: **Uppsala University** · enrollment: 174 (actual)

## Conditions studied

- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **PROCEDURE:** Autologous hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT05029206
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-05
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2023-11-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05029206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05029206, "Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05029206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*